3 assets in Inherited Obesity

Therapeutic assets addressing Inherited Obesity, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Setmelanotide Inherited Obesity	Rhythm Pharmaceuticals, Inc.	P3	BBB (73)
Mibavademab Inherited Obesity	Regeneron Pharmaceuticals	P3	B (60)